fbpx
June 13, 2022

Analysis Shows Predictive Capabilities of Sleep EEG Analysis Shows Predictive Capabilities of Sleep EEG

CHARLOTTE, N.C. – Overnight sleep electroencephalography (EEG) contains an abundance of brain wave data that could be mined to identify an individual’s risk for a host […]
June 10, 2022

Rare APOE Variants Reduce Alzheimer’s Risk by More Than 60% Rare APOE Variants Reduce Alzheimer’s Risk by More Than 60%

Two rare mutations in the APOE gene ― APOE ε4 (R251G) and APOE ε3 (V236E) ― dramatically reduce the risk of developing Alzheimer’s disease (AD), results […]
June 10, 2022

Surprising Link Between Herpes Zoster and Dementia Surprising Link Between Herpes Zoster and Dementia

Herpes zoster does not appear to increase dementia risk ― on the contrary, the viral infection may offer some protection, a large population-based study suggests. “We […]
June 10, 2022

Children With Mild TBI at Risk for Behavioral and Emotional Problems Children With Mild TBI at Risk for Behavioral and Emotional Problems

The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Mild traumatic brain injury […]
June 10, 2022

Sleep a Neglected Pillar of Health, National Survey Shows Sleep a Neglected Pillar of Health, National Survey Shows

Physicians and patients agree on the importance of sleep for health, yet few clinicians obtain a patient sleep history, and few patients discuss their sleep problems […]
June 10, 2022

Novel Drug Tied to Slowed Disease Progression in Relapsing MS Novel Drug Tied to Slowed Disease Progression in Relapsing MS

NATIONAL HARBOR, Maryland — Ublituximab (TG Therapeutics, Inc), an investigational anti-CD20 monoclonal antibody infused once every 6 months, is effective for treating relapsing forms of multiple […]
June 9, 2022

Novel Drug Safe, Effective in Relapsing MS: 2-Year Data Novel Drug Safe, Effective in Relapsing MS: 2-Year Data

NATIONAL HARBOR, Maryland — Evobrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor for relapsing multiple sclerosis (RMS), is relatively safe and effective over the long-term, new […]
June 9, 2022

‘Genetic’ Height Linked to Peripheral Neuropathy, Other Disorders ‘Genetic’ Height Linked to Peripheral Neuropathy, Other Disorders

A person’s ‘genetic’ height – the height they are predicted to reach independent of environmental influences – may be an underappreciated risk factor for a wide […]
June 9, 2022

General Neurologists’ MS Knowledge Falls Short General Neurologists’ MS Knowledge Falls Short

NATIONAL HARBOR, MD — As multiple sclerosis (MS) therapies expand and therapeutic decision-making becomes more complex, new research shows that general neurologists fall far below MS […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0